“It is disturbing to see increased use of fentanyl on the job and in combination with other drugs, given fentanyl’s extreme potency, which can increase risk of impairment, accidents, and potential ...
Quest Diagnostics stock has reached an all-time high of $186.38, marking a significant milestone for the $20.75 billion healthcare diagnostics company. According to InvestingPro analysis, the stock ...
StockStory.org on MSN
Testing & Diagnostics Services Q2 Earnings: Guardant Health (NASDAQ:GH) is the Best in the Biz
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Due to Labcorp Holdings’ outperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic ...
JOHNSON CITY, Tenn., Sept. 18, 2025 /PRNewswire/ — LabConnect is pleased to announce the appointment of Bill Finger as Senior Vice President, Global Strategic Services, effective Wednesday, September ...
Stakeholders noted that challenges like supply chain breakdowns and staffing shortages are too global in scope for any one ...
The Non-Invasive Prenatal Testing (NIPT) market is expected to grow at a moderate CAGR between 2025 and 2032. According to ...
Exact Sciences drives growth through innovation in cancer detection, with strong products and a promising pipeline. Find out why EXAS stock is a buy.
Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback